Moreover, the bombesin-functionalized nanosystem obtained from the kit ([99mTc]Tc-AuNP–Lys3-bombesin) showed 1.8 times higher uptake in prostate cancer cells than non-targeted NPs. This evidence concerns the gene GRP and prostate carcinoma.